Prometheus

Funding Opportunity Number: DARPA-BAA-16-42 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantOtherProcurement ContractCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.910Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-DARPA-BTOClosing Date: Aug 02, 2016Award Ceiling: Expected Number of Awards: Creation Date: Jun 15, 2016Funding Opportunity Description: The Prometheus program aims to develop a molecular host prognostic assay to measure infectious disease contagiousness. Prometheus will focus specifically on the early prognosis of pathogen transmission potential prior to the onset of symptoms. By the end of the program, a minimal set of early host biomarkers will be identified in humans that correlate with and predict contagiousness
Source: Grants.gov - Category: Research Tags: Science and Technology and other Research and Development Source Type: funding